BACKGROUND AND PURPOSE:There is considerable variability in the clinical behavior and treatment response of low-grade (WHO grade II) gliomas. The purpose of this work was to characterize the metabolic profile of low-grade gliomas by using short echo time 1 H-MR spectroscopy and to correlate metabolite levels with MR imaging-measured sodium ( 23 Na) signal intensity. Based on previous studies, we hypothesized decreased N-acetylaspartate (NAA) and increased myo-inositol (mIns), choline (Cho), glutamate (Glu), and 23 Na signal intensity in glioma tissue.